Research Study
View Full Study →
Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway.
Citation
Zeng Y., Xiong L., Tang H., Chen L., Yu Q. et al. (2024). Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway.. J Ethnopharmacol. DOI: 10.1016/j.jep.2024.118498
Abstract
Abstract not available. See citation for source.
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.